Feb 2, 2026 By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) - The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain with U.S
Some people will not have elevated liver enzymes ever
Impact of comorbid conditions on asthmatic adults and children
LegitScript verified Active members: 150,000+ The full medication menu includes compounded semaglutide and tirzepatide injections, GLP-1 liquid drops, GLP-1 lozenges, oral semaglutide liposomal tablets, the FDA-approved Foundayo pill, brand-name Wegovy and Zepbound, plus several non-GLP-1 weight-loss medications like metformin, naltrexone-bupropion, and topiramate combinations